Prostaglandin inhibition of metabolically induced coronary vasodilation.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects*; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D005246:Feedback; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010477:Perfusion; D011217:Practolol / Q000494:pharmacology; D011448:Prostaglandin Antagonists; D012044:Regression Analysis; D014159:Transducers
D011448:Prostaglandin Antagonists; D004246:Dimethylphenylpiperazinium Iodide; D005996:Nitroglycerin; D007545:Isoproterenol; D000109:Acetylcholine; D010100:Oxygen; D011217:Practolol; D009638:Norepinephrine; D004837:Epinephrine